{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:59:18Z","timestamp":1783717158895,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Research Foundation of the Region of Southern Denmark"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00223-017-0363-3","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T13:53:06Z","timestamp":1510753986000},"page":"321-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-2808","authenticated-orcid":false,"given":"Vikram Vinod","family":"Shanbhogue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stinus","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-9217","authenticated-orcid":false,"given":"Signe Sparre","family":"Beck-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"363_CR1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-08-0818","volume":"160","author":"SS Beck-Nielsen","year":"2009","unstructured":"Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 160:491\u2013497","journal-title":"Eur J Endocrinol"},{"key":"363_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","volume":"92","author":"A Martin","year":"2012","unstructured":"Martin A, David V, Quarles LD (2012) Regulation and function of the FGF23\/klotho endocrine pathways. Physiol Rev 92:131\u2013155","journal-title":"Physiol Rev"},{"key":"363_CR3","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","volume":"25","author":"A Martin","year":"2011","unstructured":"Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, Quarles LD (2011) Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J 25:2551\u20132562","journal-title":"FASEB J"},{"issue":"2","key":"363_CR4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"F Francis","year":"1995","unstructured":"Francis F, Hennig S, Korn B, Reinhardt R, De Jong P, Poustka A, Lehrach H, Rowe PS, Goulding JN, Summerfield T, Mountford R (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11(2):130\u2013136","journal-title":"Nat Genet"},{"key":"363_CR5","first-page":"722","volume":"118","author":"B Yuan","year":"2008","unstructured":"Yuan B, Takaiwa M, Clemens TL, Feng JQ, Kumar R, Rowe PS, Xie Y, Drezner MK (2008) Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest 118:722\u2013734","journal-title":"J Clin Invest"},{"key":"363_CR6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","volume":"35","author":"A Benet-Pages","year":"2004","unstructured":"Benet-Pages A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM (2004) FGF23 is processed by proprotein convertases but not by PHEX. Bone 35:455\u2013462","journal-title":"Bone"},{"issue":"3","key":"363_CR7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11914-014-0223-2","volume":"12","author":"KE White","year":"2014","unstructured":"White KE, Hum JM, Econs MJ (2014) Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis. Curr Osteoporos Rep 12(3):252\u2013262","journal-title":"Curr Osteoporos Rep"},{"key":"363_CR8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jbmr.110","volume":"25","author":"WN Addison","year":"2010","unstructured":"Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695\u2013705","journal-title":"J Bone Miner Res"},{"key":"363_CR9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.1766","volume":"28","author":"NM Barros","year":"2013","unstructured":"Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, Carmona AK, McKee MD (2013) Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J Bone Miner Res 28:688\u2013699","journal-title":"J Bone Miner Res"},{"key":"363_CR10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2010.091231","volume":"177","author":"T Boukpessi","year":"2010","unstructured":"Boukpessi T, Gaucher C, Leger T, Salmon B, Le FJ, Willig C, Rowe PS, Garabedian M, Meilhac O, Chaussain C (2010) Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin. Am J Pathol 177:803\u2013812","journal-title":"Am J Pathol"},{"key":"363_CR11","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.1.05989","volume":"183","author":"D Bresler","year":"2004","unstructured":"Bresler D, Bruder J, Mohnike K, Fraser WD, Rowe PS (2004) Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets. The Journal of endocrinology 183:R1\u2013R9","journal-title":"The Journal of endocrinology"},{"key":"363_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bone.2016.11.019","volume":"95","author":"T Boukpessi","year":"2016","unstructured":"Boukpessi T, Hoac B, Coyac BR et al (2016) Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia. Bone 95:151\u2013161","journal-title":"Bone"},{"key":"363_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0221-8747(81)80020-3","volume":"3","author":"PJ Marie","year":"1981","unstructured":"Marie PJ, Glorieux FH (1981) Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Relat Res 3:31\u201338","journal-title":"Metab Bone Dis Relat Res"},{"key":"363_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(91)90507-T","volume":"90","author":"IR Reid","year":"1991","unstructured":"Reid IR, Murphy WA, Hardy DC, Teitelbaum SL, Bergfeld MA, Whyte MP (1991) X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. Am J Med 90:63\u201369","journal-title":"Am J Med"},{"key":"363_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bone.2013.01.046","volume":"54","author":"JQ Feng","year":"2013","unstructured":"Feng JQ, Clinkenbeard EL, Yuan B, White KE, Drezner MK (2013) Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia. Bone 54:213\u2013221","journal-title":"Bone"},{"key":"363_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","volume":"87","author":"SS Beck-Nielsen","year":"2010","unstructured":"Beck-Nielsen SS, Brusgaard K, Rasmussen LM et al (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108\u2013119","journal-title":"Calcif Tissue Int"},{"key":"363_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0169-6009(91)90038-2","volume":"12","author":"MB Oliveri","year":"1991","unstructured":"Oliveri MB, Cassinelli H, Bergada C, Mautalen CA (1991) Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH). Bone Miner 12:91\u2013100","journal-title":"Bone Miner"},{"key":"363_CR18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00003072-199307000-00004","volume":"18","author":"L Rosenthall","year":"1993","unstructured":"Rosenthall L (1993) DEXA bone densitometry measurements in adults with X-linked hypophosphatemia. Clin Nucl Med 18:564\u2013566","journal-title":"Clin Nucl Med"},{"key":"363_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s002560050016","volume":"29","author":"RM Shore","year":"2000","unstructured":"Shore RM, Langman CB, Poznanski AK (2000) Lumbar and radial bone mineral density in children and adolescents with X-linked hypophosphatemia: evaluation with dual X-ray absorptiometry. Skeletal Radiol 29:90\u201393","journal-title":"Skeletal Radiol"},{"key":"363_CR20","first-page":"147","volume":"66","author":"GS Reusz","year":"1995","unstructured":"Reusz GS (1995) Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets. Acta Bio med Ateneo Parmense 66:147\u2013151","journal-title":"Acta Bio med Ateneo Parmense"},{"key":"363_CR21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381\u20131388","journal-title":"J Bone Miner Res"},{"key":"363_CR22","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K et al (2014) The rapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr connect 3:R13\u2013R30","journal-title":"Endocr connect"},{"key":"363_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1651-2227.1993.tb12848.x","volume":"388","author":"CF Verge","year":"1993","unstructured":"Verge CF, Cowell CT, Howard NJ, Donaghue KC, Silink M (1993) Growth in children with X-linked hypophosphataemic rickets. Acta paediatrica 388:70\u201375","journal-title":"Acta paediatrica"},{"key":"363_CR24","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","volume":"325","author":"CF Verge","year":"1991","unstructured":"Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Eng J Med 325:1843\u20131848","journal-title":"N Eng J Med"},{"key":"363_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02405074","volume":"35","author":"PJ Marie","year":"1983","unstructured":"Marie PJ, Glorieux FH (1983) Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int 35:443\u2013448","journal-title":"Calcif Tissue Int"},{"key":"363_CR26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","volume":"303","author":"FH Glorieux","year":"1980","unstructured":"Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023\u20131031","journal-title":"N Engl J Med"},{"key":"363_CR27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jbmr.2310","volume":"30","author":"VV Shanbhogue","year":"2015","unstructured":"Shanbhogue VV, Hansen S, Folkestad L, Brixen K, Beck-Nielsen SS (2015) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets. J Bone Miner Res 30:176\u2013183","journal-title":"J Bone Miner Res"},{"key":"363_CR28","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI111900","volume":"75","author":"RM Harrell","year":"1985","unstructured":"Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK (1985) Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Investig 75:1858\u20131868","journal-title":"J Clin Investig"},{"key":"363_CR29","first-page":"879","volume":"75","author":"W Sullivan","year":"1992","unstructured":"Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K (1992) A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 75:879\u2013885","journal-title":"J Clin Endocrinol Metab"},{"key":"363_CR30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/jhg.2012.56","volume":"57","author":"SS Beck-Nielsen","year":"2012","unstructured":"Beck-Nielsen SS, Brixen K, Gram J, Brusgaard K (2012) Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet 57:453\u2013458","journal-title":"J Hum Genet"},{"key":"363_CR31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","volume":"87","author":"SS Beck-Nielsen","year":"2010","unstructured":"Beck-Nielsen SS, Brusgaard K, Rasmussen LM et al (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108\u2013119","journal-title":"Calcif Tissue Int"},{"key":"363_CR32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/000456329703400606","volume":"34","author":"WD Fraser","year":"1997","unstructured":"Fraser WD, Durham BH, Berry JL, Mawer EB (1997) Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem 34:632\u2013637","journal-title":"Ann Clin Biochem"},{"key":"363_CR33","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","volume":"100","author":"J Connor","year":"2015","unstructured":"Connor J, Olear EA, Insogna KL et al (2015) Conventional Therapy in Adults With X-Linked Hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100:3625\u20133632","journal-title":"J Clin Endocrinol Metab"},{"key":"363_CR34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SA Burnett","year":"2006","unstructured":"Burnett SA, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone MinerRes 21:1187\u20131196","journal-title":"J Bone MinerRes"},{"key":"363_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2265.2003.01685.x","volume":"58","author":"O Makitie","year":"2003","unstructured":"Makitie O, Kooh SW, Sochett E (2003) Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol 58:163\u2013168","journal-title":"Clin Endocrinol"},{"key":"363_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2013.03.009","volume":"55","author":"TD Vu","year":"2013","unstructured":"Vu TD, Wang XF, Wang Q et al (2013) New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone. Bone 55:57\u201363","journal-title":"Bone"},{"key":"363_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11926-015-0523-2","volume":"17","author":"F Bandeira","year":"2015","unstructured":"Bandeira F, Cassibba S (2015) Hyperparathyroidism and bone health. Curr Rheumatol Rep 17:48","journal-title":"Curr Rheumatol Rep"},{"key":"363_CR38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00774-004-0594-z","volume":"23","author":"I Ros","year":"2005","unstructured":"Ros I, Alvarez L, Guanabens N, Peris P, Monegal A, Vazquez I, Cerda D, Ballesta AM, Munoz-Gomez J (2005) Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab 23:266\u2013269","journal-title":"J Bone Miner Metab"},{"key":"363_CR39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jcph.570","volume":"56","author":"X Zhang","year":"2016","unstructured":"Zhang X, Imel EA, Ruppe MD et al (2016) Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. J Clin Pharmacol 56:176\u2013185","journal-title":"J Clin Pharmacol"},{"key":"363_CR40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0221-8747(81)90002-3","volume":"3","author":"PJ Marie","year":"1981","unstructured":"Marie PJ, Glorieux FH (1981) Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets. Metab Bone Dis Relat Res 3:159\u2013164","journal-title":"Metab Bone Dis Relat Res"},{"key":"363_CR41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jcem-52-3-463","volume":"52","author":"T Costa","year":"1981","unstructured":"Costa T, Marie PJ, Scriver CR, Cole DE, Reade TM, Nogrady B, Glorieux FH, Delvin EE (1981) X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. Journal Clin Endocri Metab 52:463\u2013472","journal-title":"Journal Clin Endocri Metab"},{"key":"363_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(91)90507-T","volume":"90","author":"IR Reid","year":"1991","unstructured":"Reid IR, Murphy WA, Hardy DC, Teitelbaum SL, Bergfeld MA, Whyte MP (1991) X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. Am J Med 90:63\u201369","journal-title":"Am J Med"},{"key":"363_CR43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","volume":"375","author":"RM Zebaze","year":"2010","unstructured":"Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, Mackie EJ, Seeman E (2010) Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 375:1729\u20131736","journal-title":"Lancet"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0363-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T17:27:44Z","timestamp":1719595664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0363-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0363-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]}}}